Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2026 Filed Oct 14, 2026 00:47 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $73.59 | $36,795.00 |
DisclosureSEC source: 0001938861-26-000028 · wk-form4_1791938859.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,424 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| September 29, 2026 Filed Sep 30, 2026 20:52 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 2,850 | $73.00 | $208,050.00 |
DisclosureSEC source: 0001674236-26-000024 · wk-form4_1790801532.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,993 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 20:20 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 5,400 | $71.00 | $383,400.00 |
DisclosureSEC source: 0001822629-26-000016 · wk-form4_1789590049.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 339,089 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 00:56 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $70.79 | $35,395.00 |
DisclosureSEC source: 0001938861-26-000026 · wk-form4_1789433811.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,924 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 00:57 UTC |
Thoma JeanneDirector
|
SaleCommon Stock | 1,000 | $71.53 | $71,530.00 |
DisclosureSEC source: 0001819879-26-000006 · wk-form4_1789433836.xml · nonDerivative · entry 1 Thoma Jeanne · CIK 0001819879 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,762 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026. Read SEC document |
| August 31, 2026 Filed Sep 1, 2026 22:18 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 2,850 | $72.80 | $207,480.00 |
DisclosureSEC source: 0001674236-26-000022 · wk-form4_1788301118.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $71.89 to $73.36. The price reported above reflects the weighted average sales price. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 22:15 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 5,400 | $74.30 | $401,220.00 |
DisclosureSEC source: 0001822629-26-000014 · wk-form4_1787782508.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $73.58 to $74.61. The price reported above reflects the weighted average sales price. Read SEC document |
| August 19, 2026 Filed Aug 27, 2026 20:21 UTC |
Gosebruch Henry ODirector
|
GrantCommon Stock | 6,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001659625-26-000011 · wk-form4_1787862115.xml · nonDerivative · entry 1 Gosebruch Henry O · CIK 0001659625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,662 F1 · balance_after: Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of August 19, 2026. Read SEC document |
| August 13, 2026 Filed Aug 13, 2026 20:32 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $75.48 | $37,740.00 |
DisclosureSEC source: 0001938861-26-000023 · wk-form4_1786653146.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,424 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 00:57 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 3,162 | $77.00 | $243,474.00 |
DisclosureSEC source: 0001846478-26-000015 · wk-form4_1786496247.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,534 Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:02 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 2,850 | $81.36 | $231,876.00 |
DisclosureSEC source: 0001674236-26-000019 · wk-form4_1785441772.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 174,693 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $80.61 to $81.88. The price reported above reflects the weighted average sales price. Read SEC document |
| July 18, 2026 Filed Jul 21, 2026 20:32 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 2,466 | $79.20 | $195,307.20 |
DisclosureSEC source: 0001938861-26-000021 · wk-form4_1784665922.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,924 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 20:02 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $81.84 | $40,920.00 |
DisclosureSEC source: 0001938861-26-000019 · wk-form4_1784059323.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,313 | $49.51 Strike: $49.51 | $164,026.63 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · derivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,313 Underlying: Common Stock · 3,313 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 3,313 | $86.00 | $284,918.00 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,543 F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionCommon Stock | 3,313 | $49.51 | $164,026.63 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 20:14 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 2,850 | $84.12 | $239,742.00 |
DisclosureSEC source: 0001674236-26-000015 · wk-form4_1782850477.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,543 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $83.39 to $84.63. The price reported above reflects the weighted average sales price. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 22:44 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $82.03 | $41,015.00 |
DisclosureSEC source: 0001938861-26-000017 · wk-form4_1781563468.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,890 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| June 08, 2026 Filed Jun 11, 2026 01:06 UTC |
HAUGHEY THOMASDirector
|
SaleCommon Stock | 2,000 | $80.88 | $161,760.00 |
DisclosureSEC source: 0001272247-26-000004 · wk-form4_1781140013.xml · nonDerivative · entry 2 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,878 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,312 | $49.51 Strike: $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · derivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,626 Underlying: Common Stock · 3,312 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 3,312 | $80.00 | $264,960.00 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,393 F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionCommon Stock | 3,312 | $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:10 UTC |
Thoma JeanneDirector
|
GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001819879-26-000003 · wk-form4_1781140220.xml · nonDerivative · entry 1 Thoma Jeanne · CIK 0001819879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,762 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:09 UTC |
TANNENBAUM RENEE PDirector
|
GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001543174-26-000003 · wk-form4_1781140154.xml · nonDerivative · entry 1 TANNENBAUM RENEE P · CIK 0001543174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,514 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:08 UTC |
Pera Antonio RDirector
|
GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001689325-26-000003 · wk-form4_1781140099.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,017 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:08 UTC |
Leonard Matthew JDirector
|
GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001773152-26-000003 · wk-form4_1781140081.xml · nonDerivative · entry 1 Leonard Matthew J · CIK 0001773152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,221 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| May 21, 2026 Filed Jun 11, 2026 01:06 UTC |
HAUGHEY THOMASDirector
|
GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001272247-26-000004 · wk-form4_1781140013.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,878 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| May 13, 2026 Filed May 14, 2026 00:22 UTC |
Walsh Patrick DDirector
|
SaleCommon Stock | 10,000 | $80.63 | $806,300.00 |
DisclosureSEC source: 0001720568-26-000005 · wk-form4_1778718127.xml · nonDerivative · entry 2 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,432 Read SEC document |
| May 13, 2026 Filed May 13, 2026 20:15 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $78.16 | $39,080.00 |
DisclosureSEC source: 0001938861-26-000015 · wk-form4_1778703326.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:16 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
SaleCommon Stock | 459 | $79.21 | $36,357.39 |
DisclosureSEC source: 0001507496-26-000012 · wk-form4_1778703407.xml · nonDerivative · entry 1 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,271 Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:15 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 2,772 | $79.50 | $220,374.00 |
DisclosureSEC source: 0001846478-26-000013 · wk-form4_1778703345.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,696 Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:22 UTC |
Walsh Patrick DDirector
|
SaleCommon Stock | 3,973 | $80.75 | $320,819.75 |
DisclosureSEC source: 0001720568-26-000005 · wk-form4_1778718127.xml · nonDerivative · entry 1 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,432 Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:16 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 55,000 | $77.57 | $4,266,350.00 |
DisclosureSEC source: 0001822629-26-000011 · wk-form4_1778703381.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,889 F1 · price: The shares were sold in multiple trades at prices ranging from $76.21 to $80.38. The price reported above reflects the weighted average sales price. Read SEC document |
| April 13, 2026 Filed Apr 13, 2026 20:40 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $77.95 | $38,975.00 |
DisclosureSEC source: 0001938861-26-000013 · wk-form4_1776112832.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,890 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| March 13, 2026 Filed Mar 13, 2026 21:28 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 3,162 | $71.64 | $226,525.68 |
DisclosureSEC source: 0001846487-26-000014 · wk-form4_1773437295.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price. Read SEC document |
| March 13, 2026 Filed Mar 13, 2026 21:28 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 500 | $72.62 | $36,310.00 |
DisclosureSEC source: 0001938861-26-000010 · wk-form4_1773437283.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 21:28 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
SaleCommon Stock | 4,772 | $74.91 | $357,470.52 |
DisclosureSEC source: 0001507496-26-000009 · wk-form4_1773437312.xml · nonDerivative · entry 1 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,730 Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 20:09 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 3,602 | $74.18 | $267,196.36 |
DisclosureSEC source: 0001846487-26-000012 · wk-form4_1773173381.xml · nonDerivative · entry 3 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,471 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: The shares were sold in multiple trades at prices ranging from $73.27 to $74.81. The price reported above reflects the weighted average sales price. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 20:06 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 5,087 | $74.13 | $377,099.31 |
DisclosureSEC source: 0001946439-26-000010 · wk-form4_1773173188.xml · nonDerivative · entry 2 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025. F2 · price: The shares were sold in multiple trades at prices ranging from $72.94 to $74.76. The price reported above reflects the weighted average sales price. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:09 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 3,314 | $74.04 | $245,368.56 |
DisclosureSEC source: 0001846487-26-000012 · wk-form4_1773173381.xml · nonDerivative · entry 2 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,073 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:09 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 17,060 | $74.04 | $1,263,122.40 |
DisclosureSEC source: 0001822629-26-000008 · wk-form4_1773173356.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,889 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:07 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 3,314 | $74.04 | $245,368.56 |
DisclosureSEC source: 0001846478-26-000010 · wk-form4_1773173229.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,468 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:04 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 5,150 | $74.04 | $381,306.00 |
DisclosureSEC source: 0001674236-26-000010 · wk-form4_1773173079.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,393 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 2,121 | $74.22 | $157,420.62 |
DisclosureSEC source: 0001846487-26-000012 · wk-form4_1773173381.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,387 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
SaleCommon Stock | 1,485 | $75.00 | $111,375.00 |
DisclosureSEC source: 0001946439-26-000010 · wk-form4_1773173188.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,033 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,312 | $49.51 Strike: $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · derivative · entry 4 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,938 Underlying: Common Stock · 3,312 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 4,000 | $75.56 | $302,240.00 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,543 Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 3,312 | $75.42 | $249,791.04 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,543 F1 · price: The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC |
CAREY STEPHEN P.SVP & CFO
|
Exercise / conversionCommon Stock | 3,312 | $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2026 Filed Mar 3, 2026 23:01 UTC |
Walsh Patrick DDirector
|
SaleCommon Stock | 6,000 | $74.23 | $445,380.00 |
DisclosureSEC source: 0001720568-26-000002 · wk-form4_1772578861.xml · nonDerivative · entry 1 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,405 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.